U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H18F3NO.ClH
Molecular Weight 321.766
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LANPERISONE HYDROCHLORIDE

SMILES

Cl.C[C@H](CN1CCCC1)C(=O)C2=CC=C(C=C2)C(F)(F)F

InChI

InChIKey=PHBZFPOOJUGYCR-RFVHGSKJSA-N
InChI=1S/C15H18F3NO.ClH/c1-11(10-19-8-2-3-9-19)14(20)12-4-6-13(7-5-12)15(16,17)18;/h4-7,11H,2-3,8-10H2,1H3;1H/t11-;/m1./s1

HIDE SMILES / InChI

Molecular Formula C15H18F3NO
Molecular Weight 285.3047
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Lanperisone (NK433) is muscle relaxant. It acts by blocking voltage-gated sodium channels.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
13.7 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels.
2005 Dec
Patents

Sample Use Guides

In studies of muscle relaxation effect on rats and cats, NK433 was administered either parenterally via a cannula previously inserted into the jugular, cephalic or femoral vein. In oral administration study, NK433 was dissolved in distilled water and was administered via a cannula previously inserted into the stomach. NK433 reduced the mono- and polysynaptic reflex potential at doses of 5 and 10 mg/kg, i.v.
Route of Administration: Other
Binding to Voltage-gated sodium channels was studied using [3H]batrachotoxinin A 20-alpha-benzoate ([3H]-BTX) assay with rat cerebrocortical synaptosomes. Aliquots (100 μL) equal to approximately 6 to 8 mg/ml protein were used in [3H]BTX binding experiments. Binding assays were performed in the presence of 5.0 nM [3H]BTX, 1 μΜ tetrodotoxin, 4.0 μg of scorpion toxin, and various concentrations of the added drugs at 37°C for 60-min incubation time. Nonspecific binding was determined in the presence of 300 μΜ aconitine. The reaction was terminated by rapid filtration using a UniFilter-96 GF/B (PerkinElmer Life and Analytical Sciences). The filtration plates were washed five times with ice-cold wash buffer. Radioactivity trapped on a 96-well filtration plate was measured by liquid scintillation spectrometry in 40 μL of Mi-croscint 20 scintillation cocktail. Binding affinity of lanperisone was determined to be 13.7 uM.
Substance Class Chemical
Created
by admin
on Sat Dec 16 05:12:37 GMT 2023
Edited
by admin
on Sat Dec 16 05:12:37 GMT 2023
Record UNII
JRF22NV56M
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LANPERISONE HYDROCHLORIDE
JAN  
Common Name English
1-PROPANONE, 2-METHYL-3-(1-PYRROLIDINYL)-1-(4-(TRIFLUOROMETHYL)PHENYL)-, HYDROCHLORIDE (1:1), (2R)-
Common Name English
NK-433
Code English
(-)-LANPERISONE HYDROCHLORIDE
Common Name English
1-PROPANONE, 2-METHYL-3-(1-PYRROLIDINYL)-1-(4-(TRIFLUOROMETHYL)PHENYL)-, HYDROCHLORIDE, (2R)-
Systematic Name English
1-PROPANONE, 2-METHYL-3-(1-PYRROLIDINYL)-1-(4-(TRIFLUOROMETHYL)PHENYL)-, HYDROCHLORIDE, (R)-
Systematic Name English
NK433
Code English
LANPERISONE HYDROCHLORIDE [JAN]
Common Name English
Code System Code Type Description
CAS
116287-13-9
Created by admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
PRIMARY
FDA UNII
JRF22NV56M
Created by admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
PRIMARY
CHEBI
31762
Created by admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
PRIMARY
PUBCHEM
198706
Created by admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
PRIMARY
EPA CompTox
DTXSID4048856
Created by admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY